Tuesday 17 November 2026
Export KYNB’s income statement to Excel — free account
Kyntra Bio Inc
KYNBKyntra Bio Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.4 million, down 78.3% from fiscal 2024.
- Revenue
- n/m
- EPS
- n/m
- Free cash flow
- n/m
Quarter to June 2026, against a year earlier
3.11
0.33
−9.59%
Follow KYNB
Alert me
Where the cash went Fiscal 2025, year to 31 December 2025
Free cash flow was −$4.8M: capital expenditures were more than operating cash flow. Cash fell by $54.3M. Lines the picture does not name came to −$4.4M. What is a cash flow statement?
- Free cash flow
- −$4.8M
- Returned to shareholders
- $0.00
- Debt, net
- −$80.6M repaid
- Change in cash
- −$54.3M over the period
| Operating cash flow | 0.0 |
|---|---|
| Capital expenditures | 0.0 |
| Free cash flow | 0.0 |
| Acquisitions, net | +0.1 |
| Into investments, net | −0.1 |
| Debt repaid, net | −0.1 |
| Other | 0.0 |
| Change in cash | −0.1 |
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $0.0B | −$0.1B | −$0.1B | −$0.1B | $0.1B | −$0.1B | −$0.1B | −$0.3B | −$0.1B | $0.0B |
| Capex | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Free cash flow | $0.0B | −$0.1B | −$0.1B | −$0.1B | $0.1B | −$0.1B | −$0.1B | −$0.3B | −$0.1B | $0.0B |
Figures in billions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
(58.07) | (120.87) | (86.42) | (76.97) | (189.29) | (290.02) | (293.65) | (284.23) | (47.58) | 183.45 |
Depreciation & Amortization |
8.77 | 7.94 | 6.52 | 17.79 | 22.15 | 17.29 | 12.22 | 4.87 | 1.01 | 0.68 |
Non Cash Items (Other) |
31.88 | 37.40 | 52.15 | 66.14 | 74.11 | 130.42 | 65.07 | 84.03 | 26.03 | (35.87) |
Accounts Receivable Change |
4.96 | 2.00 | (55.23) | 35.23 | (11.97) | 25.18 | 0.77 | 3.43 | (6.74) | (2.54) |
Change in inventories |
— | — | — | (6.89) | (9.17) | (14.16) | (11.00) | (1.69) | 22.28 | 5.36 |
Accounts Payable Change |
(0.30) | (0.71) | 3.63 | (3.05) | 17.73 | 0.81 | 5.91 | (15.51) | 14.51 | (27.65) |
Change in payables and accrued liability |
2.97 | 9.20 | 5.61 | 17.71 | 30.91 | 16.38 | 90.56 | (49.78) | (91.53) | (45.51) |
Change in other assets and liabilities |
16.90 | (1.46) | (2.40) | (128.66) | 147.13 | 31.88 | (15.80) | (56.13) | (55.98) | (82.69) |
Operating Cash Flow |
7.11 | (66.51) | (76.14) | (78.70) | 81.60 | (82.23) | (145.93) | (315.02) | (138.00) | (4.77) |
Capital expenditures |
(1.25) | (8.49) | (7.84) | (5.75) | (3.99) | (5.19) | (3.73) | (2.52) | 0.78 | (0.04) |
Change in intangibles (net) |
— | — | — | — | 0.00 | (25.00) | (35.00) | — | — | — |
Net Aquisitions |
— | — | — | — | — | — | — | — | — | 96.62 |
Short Term Investments Change (Net) |
7.87 | (0.17) | (576.88) | (411.30) | 2.41 | (479.93) | (156.64) | (245.10) | (8.63) | (61.16) |
Long-Term Investments Change (Net) |
— | 78.53 | 62.59 | 537.07 | 454.07 | 83.14 | 284.49 | 400.62 | 133.84 | — |
Other investing activities |
(2.74) | (9.24) | (15.61) | (12.75) | (11.46) | (32.37) | 8.13 | 0.66 | — | — |
Investing cash flow |
6.62 | 69.87 | (522.12) | 120.02 | 452.49 | (426.97) | 89.12 | 153.66 | 125.99 | 35.42 |
Repayment/Issuance of Debt (Net) |
(0.40) | (0.40) | (0.36) | (12.33) | (13.02) | (5.89) | (0.54) | 73.59 | (0.04) | (80.56) |
Equity Repurchase (Common, Net) |
9.88 | 506.12 | 29.85 | 20.78 | 37.83 | 12.70 | 4.18 | 52.14 | 0.14 | — |
Other financial activities |
(2.74) | (9.24) | (15.61) | (12.75) | (11.46) | (7.37) | 43.13 | (2.98) | (0.35) | (5.47) |
Financing cash flow |
6.74 | 496.47 | 13.88 | (4.30) | 13.34 | (0.56) | 46.78 | 122.75 | (0.25) | (86.03) |
Exchange Rate Adjustment |
(0.01) | 0.05 | (0.01) | 0.00 | 4.70 | 2.60 | (5.48) | (3.40) | 0.75 | 1.08 |
Change in Cash |
20.46 | 499.88 | (584.40) | 37.01 | 552.13 | (507.17) | (15.52) | (42.01) | (11.51) | (54.31) |
Beginning Cash |
153.32 | 173.78 | 673.66 | 89.26 | 126.27 | 678.39 | 171.22 | 155.70 | 113.69 | 102.18 |
Ending Cash |
173.78 | 673.66 | 89.26 | 126.27 | 678.39 | 171.22 | 155.70 | 113.69 | 102.18 | 47.87 |
Stock Based Compensation |
32.13 | 37.54 | 52.14 | 66.27 | 72.72 | 71.16 | 65.60 | 50.77 | 25.22 | 6.58 |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
24.52 | 9.02 | (48.40) | (85.66) | 174.63 | 60.08 | 70.43 | (119.69) | (117.46) | (153.03) |
Investments Change (Net) |
7.87 | 78.36 | (514.29) | 125.77 | 456.48 | (396.79) | 127.85 | 155.52 | 125.21 | (61.16) |
Issuance/Purchase of Shares |
9.88 | 506.12 | 29.85 | 20.78 | 37.83 | 12.70 | 4.18 | 52.14 | 0.14 | — |
| Other line items | ||||||||||
Revenue per Employee |
0.50 | 0.31 | 0.46 | 0.48 | 0.29 | 0.42 | 0.24 | 0.10 | 0.13 | 0.19 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 25 Oct 2026